Meningitis-Linked Pharmacy Loses Control of Its Chapter 11
New England Compounding Pharmacy Inc. executives lost control of the administration of its chapter 11 case when a bankruptcy court judge on Thursday appointed a trustee to represent the pharmacy for the remainder of the case, Dow Jones DBR Small Cap reported today. The court's decision comes in the days following revelations that the company's four executives and shareholders were paid $16.43 million last year and transferred an additional $4.84 million to three affiliated companies that they also owned.